The debate highlighted that most promising targets (VAMP2, ESCRT, fascin-1) are essential for basic cellular processes, but the specific dosing/timing parameters that could block tau transfer while preserving normal function remain undefined. This knowledge gap is critical for determining therapeutic feasibility. Source: Debate session sess_SDA-2026-04-04-gap-tau-prop-20260402003221 (Analysis: SDA-2026-04-04-gap-tau-prop-20260402003221)
Landscape Summary: What is the therapeutic window between tau propagation inhibition and essential cellular function disruption? is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
What is the therapeutic window between tau propagation inhibition and essential cellular function disruption? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: